1.
Kim SJ, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang D-H, Kook H, Kang HJ, Ahn HS, Yoon S-S, Sohn SK, Min YH, Min W-S, Park H-S, Won JH. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica [Internet]. 2010Oct.31 [cited 2026Nov.22];95(11):1935-42. Available from: https://haematologica.org/article/view/5791